24H | Summit Therapeutics Surges 18%; Navitas Semiconductor Jumps 12%; Fair Isaac Sinks 9%

US Overnight
09/29

Dow Futures rose 0.01%, S&P 500 Futures rose 0.03%, Nasdaq Futures rose 0.07% as sentiment leaned cautiously constructive amid light, steady overnight flows.

Summit Therapeutics shares surged 18.35% in overnight trading. Summit said that British drugmaker AstraZeneca would invest $2 billion in ​the company and collaborate on a ‌series of studies testing their cancer treatments together.

Navitas Semiconductor jumped 12.28% in overnight trading. The move followed a U.S. Army ALATTIS award, sponsored by the Army Research Laboratory, to design, fabricate, and test 10 kV silicon‑carbide power devices and validate a domestic manufacturing process for ultra‑high‑voltage semiconductors, alongside a deepening collaboration with MagnaChip that includes a recent equity investment and licensing of GeneSiC high‑voltage SiC technology for mission‑critical military systems.

Fair Isaac tumbled 9.06%. The decline came amid FHFA measures to adopt a unified pricing table and a dual‑score framework that incorporates VantageScore alongside FICO across agency products at Fannie Mae and Freddie Mac, and after officials alleged per‑person credit‑score costs jumped about 1,800% since 2020, intensifying competitive pressure on its mortgage credit‑scoring franchise.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10